<![CDATA[Hansa Biopharma and Genethon announce collaboration]]>Hansa Biopharma and Genethon announce collaboration to develop imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies

Link Preview Image
Hansa Biopharma and Genethon announce collaboration to develop imlifidase as pre-treatment to gene therapy in Crigler-Najjar syndrome patients with anti-AAV antibodies | Hansa Biopharma

favicon

(www.hansabiopharma.com)

]]>https://dev.proinvestor.com/forum/topic/445016/hansa-biopharma-and-genethon-announce-collaborationRSS for NodeThu, 25 Jun 2026 12:25:59 GMTThu, 27 Apr 2023 14:32:10 GMT60